Carlyle Group Inc. - 18 Apr 2025 SCHEDULE 13D/A Report for NuCana plc Ordinary Shares, nominal value (pound)0.04 per share (NCNA)

Filing Manager
Carlyle Group Inc.
Reporting Manager
The Carlyle Group Inc.
Security
NuCana plc Ordinary Shares, nominal value (pound)0.04 per share
Symbol
NCNA
Shares outstanding
142,919,250 shares
Disclosed Ownership
3,430,062 shares
Ownership
2.4%
Form type
SCHEDULE 13D/A
Filing time
18 Apr 2025, 18:04:29 UTC
Date of event
18 Apr 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Carlyle Group Inc. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Chief Financial Officer 0001527166
Carlyle Holdings I GP Inc. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Managing Director and Chief Financial Officer 0001548626
Carlyle Holdings I GP Sub L.L.C. 2.4% 3,430,062 0 3,430,062 By: Carlyle Holdings I GP Inc., its sole member, /s/ Anne Frederick, attorney-in-fact John C. Redett, Managing Director and Chief Financial Officer 0001548627
Carlyle Holdings I L.P. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Managing Director 0001548628
CG Subsidiary Holdings L.L.C. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Managing Director 0001790577
TC Group, L.L.C. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Managing Director 0000933790
Carlyle Investment Management L.L.C. 2.4% 3,430,062 0 3,430,062 /s/ Anne Frederick, attorney-in-fact John C. Redett, Chief Financial Officer 0001354120
Carlyle Genesis UK LLC 2.4% 3,430,062 0 3,430,062 By: Carlyle Investment Management L.L.C., its sole member, /s/ Anne Frederick, attorney-in-fact John C. Redett, Chief Financial Officer 0001941860
Abingworth LLP 2.4% 3,430,062 0 3,430,062 /s/ John Heard John Heard, Authorized Signatory 0001397144
Abingworth Bioventures VII LP 2.4% 3,430,062 0 3,430,062 /s/ John Heard John Heard, Authorized Signatory 0001688313